INDP Indaptus Therapeutics: Multiplikator Forward P/S
The strategic vector of Indaptus Therapeutics (INDP) is focused on creating cancer treatment methods that are resilient to macro shocks. The business's forward P/S demonstrates progress on this path, where captures a new level. The complexity of utilizing killed bacteria in therapy serves as an obstacle; however, experienced management effectively controls cash flow, ensuring the stability of current clinical trials.
Rincian metrik lan analitis perusahaan Indaptus Corp (INDP)
- rega saiki lan proyeksi nilai saham:
- data kapitalisasi saham perusahaan:
- statistik nilai buku emiten:
- data liabilitas lan likuiditas perusahaan:
Total Utang marang Modal Indaptus Therapeutics|INDP - Utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas Indaptus Therapeutics|INDP - Gunggung tanggungan utang perusahaan|Utang marang nilai buku Indaptus Corp|INDP - Gedhene kewajiban jangka dawa|Kewajiban jangka cendhak perusahaan Indaptus Therapeutics|Likuiditas cepet indaptusrx.com
- data bathi bisnis lan rasio investasi:
INDP - Asil keuangan resik|Bathi mangsa ngarep Indaptus Therapeutics|INDP - Nilai perusahaan marang bathi resik|Prakiraan rega marang bathi Indaptus|INDP - Rasio nilai perusahaan marang wutah bathi|Pangali EV/EBITDA Indaptus Corp|INDP - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi resik saben saham (EPS TTM) Indaptus Therapeutics|INDP - Bathi resik saben siji saham sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan indaptusrx.com|INDP - Tambahing bathi saben saham ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Indaptus Therapeutics
- indikator dodolan lan pendapatan:
Pambiji fundamental:Indaptus Therapeutics, Inc. (INDP)
The effectiveness of Indaptus Therapeutics (INDP) immunotherapy is limited by geopolitical barriers that slow global drug registration and constrain revenue growth. The ratio of market capitalization to projected sales volume allows for a real-time assessment of market expectations regarding asset monetization, while the future P/S multiple serves as an indicator of the company's overvaluation amid regulatory risks and stagnant clinical trials.
Perusahaan pesaing
Multiplikator Forward P/S ARGX (argenx)|BioNTech Inc. (BNTX) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Abivax Corp - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake ADMA Corp ADMA|Protagonist Therapeutics (PTGX) - Rasio rega marang prakiraan pendapatan|Kapitalisasi marang prakiraan pendapatan IMVT|KNSA (Kiniksa) - Multiplikator Forward P/S|Kapitalisasi marang prakiraan pendapatan GRFS (Grifols SA)|Multiplikator Forward P/S ADPT|Multiplikator Forward P/S Celldex Corp (CLDX)|Rasio rega marang prakiraan pendapatan Aurinia Pharmaceuticals AUPH|BCRX (biocryst.com) - Rega mangsa ngarep marang pendapatan|VERA: Multiplikator forward rega marang pendapatan|Dianthus Therapeutics Inc - Rasio rega marang pendapatan sing dikarepake|PHVS (Pharvaris Corp) - Multiplikator forward rega marang pendapatan|AbCellera Corp (ABCL) - Multiplikator Forward P/S|Rasio rega marang prakiraan pendapatan Tourmaline Bio, Inc.|precigen.com (PGEN) - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator forward rega marang pendapatan PHAR (Pharming Group)|NKTR (Nektar Therapeutics Inc) - Rega forward marang dodolan|Upstream Bio Corp - Multiplikator forward rega marang pendapatan|Rasio rega marang pendapatan sing dikarepake ZBIO (Zenas Corp)|Immunome, Inc. - Multiplikator Forward P/S|Rega forward marang dodolan GOSS (gossamerbio.com)|KALV: Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Septerna, Inc. (SEPN)|Rasio rega marang prakiraan pendapatan Pieris Pharmaceuticals Inc|SVRA: Rega forward marang dodolan|Multiplikator Forward P/S RIGL|Multiplikator Forward P/S anaptysbio.com (ANAB)|Rasio rega marang prakiraan pendapatan Astria Therapeutics, Inc. ATXS|ENGN (enGene Holdings Inc) - Rega mangsa ngarep marang pendapatan|RAPT Therapeutics, Inc. - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Aerovate Therapeutics Inc|ACRS (Aclaris Therapeutics) - Multiplikator forward rega marang pendapatan|kyvernatx.com (KYTX) - Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan TLSA|CABA (Cabaletta Bio Inc.) - Rasio rega marang pendapatan sing dikarepake|Multiplikator Forward P/S VTYX|Rasio kapitalisasi marang dodolan sing dikarepake Theratechnologies, Inc|Multiplikator Forward P/S AVTX (Avalo Therapeutics, Inc)|ELDN - Multiplikator forward rega marang pendapatan|AGEN - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi marang dodolan sing dikarepake Climb Bio Inc. CLYM|ZURA: Multiplikator Forward P/S|ATYR - Rasio kapitalisasi marang dodolan sing dikarepake|Rasio rega marang prakiraan pendapatan Adagene Inc|Kapitalisasi marang prakiraan pendapatan IMA (Ikena Oncology, Inc.)|Multiplikator Forward P/S STTK|equilliumbio.com - Kapitalisasi marang prakiraan pendapatan|Rasio rega marang prakiraan pendapatan Connect Biopharma Holdings Limited CNTB|IMUX (Immunic Therapeutics) - Rega mangsa ngarep marang pendapatan|ATRA - Rasio rega marang prakiraan pendapatan|Rega mangsa ngarep marang pendapatan IFRX|XFOR: Multiplikator Forward P/S|Adicet Bio, Inc. - Rega forward marang dodolan|CELU (Celularity Inc) - Multiplikator Forward P/S|Multiplikator Forward P/S INmune Bio Corporation|Rasio rega marang prakiraan pendapatan Barinthus Biotherapeutics (BRNS)|KZR (kezarlifesciences.com) - Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan SAB Biotherapeutics, Inc. SABS|AKTX - Multiplikator forward rega marang pendapatan|Enlivex Therapeutics, Ltd. - Multiplikator Forward P/S|QTTB - Multiplikator Forward P/S|GOVX (GeoVax Labs, Inc.) - Multiplikator forward rega marang pendapatan|edesabiotech.com - Rega forward marang dodolan|IBIO (iBio) - Multiplikator Forward P/S|Carisma Tx (CARM) - Rasio kapitalisasi marang dodolan sing dikarepake|Rasio rega marang prakiraan pendapatan XTL Biopharmaceuticals, Ltd. (XTLB)|Multiplikator forward rega marang pendapatan boltbio.com BOLT|Rasio rega marang prakiraan pendapatan HCW Biologics HCWB|APVO - Multiplikator forward rega marang pendapatan|AIM: Multiplikator forward rega marang pendapatan|ADTX - Multiplikator Forward P/S|GRI Bio Corp (GRI) - Rasio rega marang prakiraan pendapatan|Kapitalisasi marang prakiraan pendapatan XRTX|HIND (Vyome Holdings Inc) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep revbiosciences.com REVB|Multiplikator Forward P/S SCNI|Rasio kapitalisasi marang dodolan sing dikarepake calcimedica.com|Rasio rega marang prakiraan pendapatan Affimed N.V. AFMD|ALLK: Kapitalisasi marang prakiraan pendapatan|HOOKIPA - Multiplikator Forward P/S|IGMS (IGM Biosciences, Inc.) - Kapitalisasi marang prakiraan pendapatan|ITOS: Multiplikator Forward P/S|Ocean Biomedical Inc (OCEA) - Multiplikator Forward P/S|Rasio rega marang prakiraan pendapatan TC BioPharm (Holdings) PLC|Third Harmonic Bio Inc - Rega mangsa ngarep marang pendapatan
